Variant report
Variant | nsv961833 |
---|---|
Chromosome Location | chr2:97722043-97724316 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:97723060-97723210 | WI-38 | lung: | n/a | n/a |
2 | CTCF | chr2:97722000-97722150 | GM12864 | blood: | n/a | n/a |
3 | CTCF | chr2:97721960-97722110 | GM12865 | blood: | n/a | n/a |
4 | CTCF | chr2:97722055-97722103 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr2:97721940-97722090 | A549 | lung: | n/a | n/a |
6 | CTCF | chr2:97722040-97722190 | MCF-7 | breast: | n/a | n/a |
7 | CTCF | chr2:97721980-97722130 | HRPEpiC | eye: | n/a | n/a |
8 | CTCF | chr2:97722000-97722150 | Hela-S3 | cervix: | n/a | n/a |
9 | CTCF | chr2:97721980-97722130 | GM12868 | blood: | n/a | n/a |
10 | CTCF | chr2:97722000-97722150 | HEK293 | kidney: | n/a | n/a |
11 | CTCF | chr2:97722060-97722210 | A549 | lung: | n/a | n/a |
12 | CTCF | chr2:97721980-97722130 | HCT-116 | colon: | n/a | n/a |
13 | CTCF | chr2:97722020-97722170 | GM12875 | blood: | n/a | n/a |
14 | CTCF | chr2:97722060-97722210 | GM12872 | blood: | n/a | n/a |
15 | STAT3 | chr2:97722612-97722791 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | TBP | chr2:97723589-97723716 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
IGKV1OR2-3 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112027519 | chr2:97722045-97722046 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs556294118 | chr2:97722103-97722104 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs554669534 | chr2:97722109-97722110 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs113628884 | chr2:97722137-97722138 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs574541537 | chr2:97722152-97722153 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs540320811 | chr2:97722207-97722208 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs553814444 | chr2:97722666-97722667 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs577276094 | chr2:97722667-97722668 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs189929734 | chr2:97722673-97722674 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs564926715 | chr2:97722719-97722720 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs370343138 | chr2:97722745-97722746 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs575434320 | chr2:97722748-97722749 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs552295637 | chr2:97723094-97723095 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs368739152 | chr2:97723127-97723128 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs79731542 | chr2:97723141-97723142 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs569343760 | chr2:97723169-97723170 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs2707337 | chr2:97723182-97723183 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs2950994 | chr2:97723614-97723615 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs9711395 | chr2:97723640-97723641 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs2314846 | chr2:97723673-97723674 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs577212608 | chr2:97723692-97723693 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs2314845 | chr2:97723701-97723702 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs539538840 | chr2:97723710-97723711 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs556650291 | chr2:97723717-97723718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74411970 | chr2:97723720-97723721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1257067 | chr2:97723721-97723722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544442552 | chr2:97723760-97723761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2872760 | chr2:97723761-97723762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369272550 | chr2:97723764-97723765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2314843 | chr2:97723776-97723777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2707339 | chr2:97723798-97723799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:97723600-97723800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |